Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Investigation
|
September 18, 1997
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist
S K Mahata, D T O'Connor, M Mahata, et al.
Journal of Human Hypertension
|
May 21, 2003
Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach
S W Chitbangonsyn, P Mahboubi, D Walker, et al.
Journal of Autonomic Pharmacology
|
June 1, 1994
Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release
M A Takiyyuddin, M R Brown, T Q Dinh, et al.
Advances in Experimental Medicine and Biology
|
February 24, 2001
Chromogranin A in human disease
D T O'Connor, S K Mahata, L Taupenot, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 13, 2001
Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequences
D T O'Connor, E A Tyrell, M T Kailasam, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1995
Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension
M T Kailasam, R J Parmer, J H Cervenka, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 1, 1996
Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk
T J Brinton, M T Kailasam, R A Wu, et al.
Current Hypertension Reports
|
September 12, 2000
Heredity and the autonomic nervous system in human hypertension
D T O'Connor, P A Insel, M G Ziegler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1991
Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies
M A Takiyyuddin, A D Baron, J H Cervenka, et al.
American Journal of Hypertension
|
September 12, 2000
Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans
V Herrmann, R Büscher, M M Go, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Investigation
|
September 18, 1997
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist
S K Mahata, D T O'Connor, M Mahata, et al.
Journal of Human Hypertension
|
May 21, 2003
Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach
S W Chitbangonsyn, P Mahboubi, D Walker, et al.
Journal of Autonomic Pharmacology
|
June 1, 1994
Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release
M A Takiyyuddin, M R Brown, T Q Dinh, et al.
Advances in Experimental Medicine and Biology
|
February 24, 2001
Chromogranin A in human disease
D T O'Connor, S K Mahata, L Taupenot, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 13, 2001
Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequences
D T O'Connor, E A Tyrell, M T Kailasam, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1995
Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension
M T Kailasam, R J Parmer, J H Cervenka, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 1, 1996
Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk
T J Brinton, M T Kailasam, R A Wu, et al.
Current Hypertension Reports
|
September 12, 2000
Heredity and the autonomic nervous system in human hypertension
D T O'Connor, P A Insel, M G Ziegler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1991
Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies
M A Takiyyuddin, A D Baron, J H Cervenka, et al.
American Journal of Hypertension
|
September 12, 2000
Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans
V Herrmann, R Büscher, M M Go, et al.
Page
of 8